A Study to Prevent Complications of High Blood Pressure Caused by Hepatitis in Patients With Cirrhosis

This study has been completed.

Sponsor:

Collaborator:

Yale University

Information provided by:

Office of Rare Diseases (ORD)

ClinicalTrials.gov Identifier:

NCT00004641

First received: February 24, 2000

Last updated: September 8, 2008

Last verified: September 2008

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	August 2007 (Final data collection date for primary outcome measure)

No publications provided by Office of Rare Diseases (ORD)

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Ripoll C, Groszmann RJ, Garcia-Tsao G, Bosch J, Grace N, Burroughs A, Planas R, Escorsell A, Garcia-Pagan JC, Makuch R, Patch D, Matloff DS; Portal Hypertension Collaborative Group. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. J Hepatol. 2009 May;50(5):923-8. Epub 2009 Mar 5.

To Top